Zhenzhen Hui

438 citations
21 papers · 290 indexed · h-index 10
Topics
Cancer Immunotherapy and Biomarkers (11 papers)Immune Cell Function and Interaction (7 papers)Immunotherapy and Immune Responses (6 papers)
Partner nations
ChinaUnited StatesSpain

In The Last Decade

Zhenzhen Hui

20 papers receiving 286 citations

Peers

Zhenzhen Hui
Comparison fields: 5 of 54
  • Oncology 208
  • Immunology 111
  • Pulmonary and Respiratory Medicine 91
  • Cardiology and Cardiovascular Medicine 59
  • Molecular Biology 49
Replace Yuying Li with:
Yuying Li China
Mahmood Al‐Dhaheri Qatar
Antonio Zanon Italy
Wala Ben Kridis Tunisia
Tomoyuki Sasaki Japan
Zhi‐Jie Cong China
Varina R. Clark United States
Ephraim Tang Canada
Teppei Yoshioka Japan
Jinxi Zuo China
Zhenzhen Hui relative to Yuying Li China Yuying Li's profile →
Citations per field
00.5×3.1×
Yuying Li · 1×
Citations per year

Countries citing papers authored by Zhenzhen Hui

Since Specialization
Citations

This map shows the geographic impact of Zhenzhen Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzhen Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzhen Hui more than expected).

Fields of papers citing papers by Zhenzhen Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzhen Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzhen Hui. The network helps show where Zhenzhen Hui may publish in the future.

Co-authorship network of co-authors of Zhenzhen Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzhen Hui. A scholar is included among the top collaborators of Zhenzhen Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzhen Hui. Zhenzhen Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 3
4 3
5 5
6 7
7 24
8 14
9 39
10 9
11 23
12 21
13 13
14 10
15 1
16 3
17 5
18 15
19 3
20 77

About Zhenzhen Hui

Zhenzhen Hui is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 290 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Oncology (208 citations), Immunology (111 citations) and Pulmonary and Respiratory Medicine (91 citations). Zhenzhen Hui has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Xiubao Ren, Xinwei Zhang, Weijiao Du, Feng Wei, Jian You, Yulong Chen, Wenwen Yu, Runmei Li, Tao Wang and Jiali Zhang. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026